Population and Public Health
Cue Health awarded $481M for coronavirus testing; public hospitals compounding COVID-19 budget risks
This week's top stories include Cue expecting to deliver six million COVID-19 molecular tests by March, while surging costs and revenue loss force hospitals to rely on support from county governments.
Dr. Art Papier, CEO of VisualDx, and Dr. Nada Elbuluk, the company's director of clinical impact, discuss the longstanding need to improve quality of care for people of color.
Deep Dive: Advocates, lawmakers and HIMSS Global Health Equity Network leaders talk about the disparities in maternal mortality and access to care among Black women, as well as the actions they're taking to address these social determinants of health.
COVID-19 is presenting challenges and opportunities for real-world data generation surrounding scale, privacy and ethics, claims Nigel Hughes, the scientific director RWD/RWE at Janssen Research and Development.
Dr. Eric J. Rubin, editor-in-chief of the New England Journal of Medicine, discusses maintaining rigorous editorial and medical standards while also exploring new ideas and concepts in a time when understanding of COVID-19 is changing by the day.
Matthew Gould, CEO of NHSx, says metrics about bed capacity, patient condition and shortages helped organize the health system during the COVID-19 pandemic.
F&D Partners CEO Frank Zhang says South Korea's health system and digital infrastructure are helping society deal with the pandemic in an efficient and transparent way, while prioritizing the citizen.
Digital maturity must be utilized to improve outcomes and manage the pandemic more effectively, claims HIMSS President and CEO Hal Wolf.
Managing the whole population during the COVID-19 crisis is posing challenges, so we should share our learning, says Päivi Sillanaukee, ambassador for Health and Wellbeing of Finland and director-general of the Finnish Ministry of Social Affairs and Health.
By adding clinical decision support and the ability to see patient activity outside the four walls of the hospital, CalvertHealth in Maryland saw, among other things, a 94% reduction in Dilaudid use.